Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) Return on Sales (2020 - 2025)

LifeStance Health (LFST) has disclosed Return on Sales for 6 consecutive years, with 0.04% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 6.0% to 0.04% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2025, up 5.0% year-over-year, with the annual reading at 0.01% for FY2025, 5.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.04% at LifeStance Health, up from 0.0% in the prior quarter.
  • The five-year high for Return on Sales was 0.04% in Q4 2025, with the low at 0.69% in Q3 2021.
  • Average Return on Sales over 5 years is 0.18%, with a median of 0.15% recorded in 2023.
  • The sharpest move saw Return on Sales crashed -66bps in 2021, then surged 52bps in 2022.
  • Over 5 years, Return on Sales stood at 0.57% in 2021, then skyrocketed by 64bps to 0.2% in 2022, then grew by 21bps to 0.16% in 2023, then soared by 86bps to 0.02% in 2024, then surged by 264bps to 0.04% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.04%, 0.0%, and 0.01% for Q4 2025, Q3 2025, and Q2 2025 respectively.